WAY-262611

Overview

WAY-262611 is a Wnt / β-Catenin agonist that increases bone formation rate with an EC 50 of 0.63 μM in TCF-Luciferase assay. WAY-262611 is also a Dkk1 inhibitor.

Application

Products | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > β-catenin | Products > Signaling Pathways > Wnt

Product Information

• Catalog No.: HY-11035
• CAS No.: 1123231-07-1
• Molecular Formula: C20H22N4
• Molecular Weight: 318.42
• Purity: 99.96%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1.67 mg/mL (5.24 mM); Clear solution
• Availability: In-stock

Source

Original product source